Efficacy and safety of 0.05% micellar nano-particulate (MNP) cyclosporine ophthalmic emulsion in the treatment of moderate-to-severe keratoconjunctivitis sicca: a 12-week, multicenter, randomized, active-controlled trial

Peer Review reports

Original Submission
8 Dec 2022	Submitted	Original manuscript
Resubmission - Version 2
	Submitted	Manuscript version 2
2 Jan 2023	Reviewed	Reviewer Report
5 Jan 2023	Reviewed	Reviewer Report
26 Jan 2023	Author responded	Author comments - Shoibal Mukherjee
Resubmission - Version 3
26 Jan 2023	Submitted	Manuscript version 3
10 Feb 2023	Reviewed	Reviewer Report
10 Feb 2023	Reviewed	Reviewer Report
Resubmission - Version 4
	Submitted	Manuscript version 4
Publishing
1 Mar 2023	Editorially accepted
27 Mar 2023	Article published	10.1186/s12886-023-02838-z

Back to article page